Cape Cod Clinical Research Inc is categorized under Medical Labs in Hyannis, MA and active since 2000.
Cape Cod Clinical Research Inc was established in 2000, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact William Baker, Owner at the company’s single location by writing to 540 Main St # 14, Hyannis, Massachusetts MA 02601 or by phoning (508) 790-4800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cape Cod Clinical Research Inc |
| Contact Person: | William Baker, Owner |
| Address: | 540 Main St # 14, Hyannis, Massachusetts 02601 |
| Phone Number: | (508) 790-4800 |
| Website Address: | cccri.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 4461100 |
| Share This Business: |
Cape Cod Clinical Research Inc was started in 2000 to provide professional Medical Labs under the SIC code 8071 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact William Baker, Owner for inquiries that concern Cape Cod Clinical Research Inc by calling the company number (508) 790-4800, as your correspondence is most welcome. Additionally, the physical location of the single location of Cape Cod Clinical Research Inc can be found at the coordinates 41.650329,-70.288902 as well as the street address 540 Main St # 14 in Hyannis, Massachusetts 02601.
For its online presence, you may visit Cape Cod Clinical Research Inc’s website at cccri.com and engage with its social media outlets through on Twitter and on Facebook.